Home › Lung Cancer › NCT00301119
Lung Cancer Biomarkers and Screening
RecruitingObservational studyHealthy volunteers welcome
NYU Lung Cancer Biomarker Center
Who can join
Ages 50 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
DISEASE CHARACTERISTICS:
* Screening Cohort
* At high- or low-risk for lung cancer
* Smoking history ≥ 20 pack years\*
* With or without workplace exposure to asbestos
* NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older
* Rule-Out Lung cancer group
* Referred for evaluation of suspicious nodules with 1 of the following diagnoses:
* Lung cancer
* Nonmalignant nodules (control group)
PATIENT CHARACTERISTICS:
* Not pregnant
* No prior malignancy except nonmelanoma skin cancer
PRIOR CONCURRENT THERAPY:
* Not specifiedAbout the study
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer.
PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Sponsor: NYU Langone Health · Participants: 3,606 · Started: 2000-05
Contact the study team
- James J. Tsay, MD, MSc · Phone: 212-598-6351
- Rosemary M Schluger · Phone: 212-263-0255
Official record on ClinicalTrials.gov — NCT00301119
Locations in the U.S.
| New York | NYU Cancer Institute at New York University Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.